Hong Kong stocks fluctuate | Chugai Pharmaceutical Co., Ltd. (06990.HK) rose over 10% in early trading, Merck & Co., Inc. and Chugai Pharmaceutical's ADC combination therapy beat K drug monotherapy
According to Zhidao Finance App, Kexing Biotech (06990.HK) rose over 10% in early trading, and as of the time of writing, it was up 7.14% at HK$486, with a trading volume of HK$1.1 billion.
Latest
